alexa Current Trends In Physician Entrepreneurship In USA, Europe, Turkey And Emerging Markets | 109200
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

33rd World Congress on Pharmacology

Barcelona, Spain
Share This Page

Current trends in physician entrepreneurship in USA, Europe, Turkey and emerging markets

Yavuz Selim Silay

Maqasid Angel Investors Network, Turkey

Keynote: Clin Pharmacol Biopharm

Pharmaceutical, biotech and medical device companies are constantly evaluating how innovation management can be improved and managing expectations of key opinion leaders. To gain these critical insights for physician entrepreneurship, our goal at society of physician entrepreneur is to accelerate innovations in order to improve healthcare. We seek to empower doctors, other healthcare providers and entrepreneurs with the information, resources, connections and experience they need to commercialize their ideas, inventions and discoveries. Currrent trends in physician entrepreneurship in USA, Europe, Turkey and emrging markets will be provided with unique cases. Dr. Yavuz Selim Silay a global leader and seasoned expert in Physician Entrepreneurship, Government engagement, Commercial Diplomacy, Corporate Communications, Government affairs & Medical Affairs will discuss how venture capital and angel invetstment networks are utilizing physician entrepreneurs to acquire these insights in a convenient, cost-effective, and compliant manner in this current changing global entrepreneurial landscape.

Yavuz Selim Silay is the Co-Founder & CEO of MaQasid Angel Investors Network (MAIN) and Chairman of Istanbul Consulting Group. He is currently the Co-Founder of BioCube İstanbul Bioentrepreneurship & Innovation Center and Corporate Communication Director of Archem Diagnostics. He previously managed the largest distributor of Siemens Healthcare in Turkey managing 250 employees and Director of Avcılar Hospital R&D Center. Previously he has worked as the Market Access & Health Policy Director for AIFD in Turkey. He has previously worked as the Vice President of Ipsen Pharmaceutical and Director of Teva Pharmaceutical in USA managing large clinical trials as well as Investigator initiated trials and developing relationships with key opinion leaders. He was the Associate Director at KV Pharmaceuticals and Director in Clinical Development Department at Forest Laboratories. He has earned his MD from the Faculty of Medicine, University of Ankara in Ankara, Turkey. He has completed a Clinical Internship at Baylor College of Medicine in Houston, followed by continued research training at The University of Texas MD Anderson Cancer Center in Houston. He recently completed his Executive MBA at the Olin Business School at Washington University in St. Louis.